Aggressive dose escalation creates extreme caloric deficits that overwhelm the body ability to preserve lean tissue
Swain RS, Taylor LG, Braver ER, Liu W, Pinheiro SP, Mosholder AD (2019) A systematic review of validated suicide outcome classification in observational studies
Semaglutide is a GLP-1based medication that may support weight loss by helping reduce appetite and improve feelings of fullness
They delay gastric emptying as to decrease the physical feeling of needing to eat and they target the brains dopamine reward pathways which can dull the reward of highly desired foods
While the gastric emptying function of incretin mimetics may facilitate weight loss, it may have gastrointestinal effects and also impact the action of other medications taken orally
Diabetes 67 , 522P (2018) A.B